Seven Eight Capital’s Immunomedics Inc IMMU Stock Holding History

Seven Eight Capital’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-22,928	Closed	-$1.95M	–	701
2020 Q3	$1.95M	Buy	22,928 +12,851	+128%	+$650K	0.42%	37
2020 Q2	$357K	Buy	+10,077	New	+$295K	0.26%	144
2020 Q1	–	Sell	-24,896	Closed	-$527K	–	802
2019 Q4	$527K	Buy	+24,896	New	+$439K	0.03%	525
2019 Q3	–	Sell	-110,980	Closed	-$1.54M	–	782
2019 Q2	$1.54M	Buy	+110,980	New	+$1.67M	0.08%	314
2018 Q4	–	Sell	-102,157	Closed	-$2.13M	–	773
2018 Q3	$2.13M	Sell	102,157 -94,300	-48%	-$2.23M	0.13%	229
2018 Q2	$4.65M	Buy	+196,457	New	+$3.95M	0.32%	102
2017 Q4	–	Sell	-14,000	Closed	-$196K	–	620
2017 Q3	$196K	Buy	+14,000	New	+$140K	0.02%	422

Seven Eight Capital's IMMU Position: Q4 2020 in Review

Seven Eight Capital sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 22,928 shares — an estimated $1.95M sold.

Seven Eight Capital first reported a position in IMMU in Q3 2017 and held it in 7 quarters. The position peaked at $4.65M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Seven Eight Capital reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Seven Eight Capital sold 22,928 Immunomedics Inc shares in Q4 2020, an estimated $1.95M.
Seven Eight Capital first reported a position in Immunomedics Inc in Q3 2017 and held it in 7 quarters.
Seven Eight Capital's Immunomedics Inc position peaked at $4.65M in Q2 2018.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Seven Eight Capital's 13F filing for Q4 2020, filed 9 Feb 2021.